Company intelligence / Profile preview
CalciMedica
La Jolla, California, United Statescalcimedica.com ↗
- Ownership
- Public · CALC
- Employees
- ~50
- Development stage
- Phase 2
01
Overview
CalciMedica’s lead asset, Auxora, is in a Phase 2 clinical trial (“KOURAGE”) targeting patients with acute kidney injury and hypoxemia. The company anticipates key data readouts from this study in mid-to-late 2025. Discussions are ongoing with the FDA regarding a potential Phase 3 program for acute pancreatitis. The company’s cash runway extends into mid–2026 following recent financing.
- Therapeutic areas
- GastroenterologyImmunologyNephrology
- Modalities
- Small molecules (CRAC channel inhibitors)
- Industry
- Biotech
02
Drug pipeline
11 assets10 more assets in the full pipeline.
03
Partnerships
Avenue Venture Opportunities Fund II, L.P. / Avenue Capital Group – credit facility partnership to support development.No major pharma partnerships disclosed publicly as of May 2025.
04
Financials
- Market cap
- $4.1M
- Total revenue
- $0
- Enterprise value
- $-14.5M
Beyond the preview
Go deeper on CalciMedica.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CalciMedica.